Newcomb Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 11710 Main St, Suite # 2, Roscoe, IL 61073 Phone: 815-623-6060 |
Dr. Richard Scott Newcomb Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11710 Main St Suite 2, Roscoe, IL 61073 Phone: 815-623-6060 Fax: 815-623-6969 |
Ryan Hansen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4775 E Rockton Rd Unit A, Roscoe, IL 61073 Phone: 815-242-9886 Fax: 815-242-9809 |
Stoneview Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 4775 E Rockton Rd Unit A, Roscoe, IL 61073 Phone: 815-242-9886 Fax: 815-242-9809 |
Dr. Sarah Elizabeth Blatchford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4906 Hononegah Rd, Roscoe, IL 61073 Phone: 815-623-3937 Fax: 815-623-8298 |
Hour Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5003 Hononegah Rd Ste 1, Roscoe, IL 61073 Phone: 815-544-9865 Fax: 815-623-8298 |
News Archive
Nearly a third of breast cancer survivors in Appalachia are not taking the critical, potentially life-saving follow-up treatment - despite having insurance that would pay for it, a troubling new study has found.
New research led by scientists at the University of Essex has given an insight into how the body finds damage in the DNA code to repair it.
In a pioneer study published in the latest issue of the scientific journal Nature Communications, a research team at the Instituto Gulbenkian de Ci-ncia (IGC; Portugal), led by Miguel Godinho Ferreira in collaboration with Isabel Gordo, show for the first time that chromosomes rearrangements (such as inversions or translocations) can provide advantages to the cells that harbor them depending on the environment they are exposed.
Presence of the genetic mutation BRAF V600E was significantly associated with increased cancer-related death among patients with papillary thyroid cancer (PTC); however, because overall mortality in PTC is low and the association was not independent of tumor characteristics, how to use this information to manage mortality risk in patients with PTC is unclear, according to a study in the April 10 issue of JAMA, a Genomics theme issue.
› Verified 5 days ago